# Amyloid-β Clearance Mechanisms in Alzheimer's Disease

> **NCT05059158** · — · RECRUITING · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 60 (estimated)

## Conditions studied

- Alzheimer's Disease (AD)

## Interventions

- **RADIATION:** positron emission tomography (PET)

## Key facts

- **NCT ID:** NCT05059158
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-01
- **Primary completion:** 2025-09
- **Final completion:** 2025-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05059158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05059158, "Amyloid-β Clearance Mechanisms in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05059158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*